CDK1 and neoplasm: MTT assay also showed that decreased cell proliferation due to CCT3 silencing was rescued by CDK1 overexpression (P < 0.001, Figure 7E), suggesting that CDK1 may serve as a downstream effect of CCT3 on tumor cell growth in melanoma.